Palvella Therapeutics (PVLA) Capital Expenditures (2014 - 2023)
Palvella Therapeutics (PVLA) reported Capital Expenditures of -$13,000 for Q4 2023, compared with -$11,000 a year earlier.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Capital Expenditures (2014 - 2023) Analysis & Trends
For FY2023, Palvella Therapeutics posted Capital Expenditures of $171,000, down 83.6% from FY2022.
- Capital Expenditures has a five-year compound annual growth rate of -36.8% (FY2018 to FY2023).
- By year, Capital Expenditures came in at $1.04 million in FY2022 (+9.7%), $949,000 in FY2021 (-65.2%), $2.73 million in FY2020 (+10.7%) and $2.46 million in FY2019 (+45.0%).
- The Q4 2023 figure ranks as the lowest quarterly Capital Expenditures since Q3 2020.
- Year over year, Capital Expenditures gained in two of the last five quarters, with growth averaging 2.1%.
- The high point for year-over-year Capital Expenditures in five years was Q2 2022 (growth of 174.7%); the low point was Q1 2021 (a decline of 98.5%).
- Per Business Quant data, the three quarters before Q4 2023 came in at $69,000 (Q3 2023), $67,000 (Q2 2023) and $48,000 (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Palvella Therapeutics | 1.99 Bn | 1.73 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -13,000.00 |
| Sep 30, 2023 | 69,000.00 |
| Jun 30, 2023 | 67,000.00 |
| Mar 31, 2023 | 48,000.00 |
| Dec 31, 2022 | -11,000.00 |
| Sep 30, 2022 | 34,000.00 |
| Jun 30, 2022 | 629,000.00 |
| Mar 31, 2022 | 389,000.00 |
| Dec 31, 2021 | 342,000.00 |
| Sep 30, 2021 | 350,000.00 |
| Jun 30, 2021 | 229,000.00 |
| Mar 31, 2021 | 28,000.00 |
| Dec 31, 2020 | 578,000.00 |
| Sep 30, 2020 | -840,000.00 |
| Jun 30, 2020 | 1.06 Mn |
| Mar 31, 2020 | 1.93 Mn |
| Dec 31, 2019 | 1.18 Mn |
| Sep 30, 2019 | 232,000.00 |
| Jun 30, 2019 | 933,000.00 |
| Mar 31, 2019 | 121,000.00 |
API Access
Palvella Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();